Shunsuke Tsuzuki, Shotaro Nakanishi, Mitsuyoshi Tamaki, Takuma Oshiro, Jun Miki, Hiroki Yamada, Tatsuya Shimomura, Takahiro Kimura, Nozomu Furuta, Seiichi Saito, et al. Initial dose reduction of enzalutamide does not decrease the incidence of adverse events in castration-resistant prostate cancer. PLOS ONE. 2021. 16. 10. e0258160-e0258160
Shotaro Nakanishi, Masato Goya, Mitsuyoshi Tamaki, Takuma Oshiro, Seiichi Saito. Three-month early change in prostate-specific antigen levels as a predictive marker for overall survival during hormonal therapy for metastatic hormone-sensitive prostate cancer. BMC research notes. 2021. 14. 1. 227-227